O'Shares Investment Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
O'Shares Investment Advisers's AMGN Position: Q2 2022 in Review
O'Shares Investment Advisers sold out of Amgen (AMGN) in Q2 2022, closing a stake of 63,614 shares — an estimated $15.4M sold.
O'Shares Investment Advisers first reported a position in AMGN in Q4 2018 and held it in 14 quarters. The position peaked at $15.7M in Q2 2021. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.
- O'Shares Investment Advisers reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
- O'Shares Investment Advisers sold 63,614 Amgen shares in Q2 2022, an estimated $15.4M.
- O'Shares Investment Advisers first reported a position in Amgen in Q4 2018 and held it in 14 quarters.
- O'Shares Investment Advisers's Amgen position peaked at $15.7M in Q2 2021.
- 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.
Based on O'Shares Investment Advisers's 13F filing for Q2 2022.